All Americans ages 6 months and older are eligible to receive an updated COVID booster tailored to a newer Omicron strain, the U.S. Centers for Disease Control and Prevention announced late Tuesday.
The agency's Advisory Committee on Immunization Practices voted 13-1 Tuesday to approve updated jabs from Moderna, Pfizer, and Novavax for the vast majority of U.S. residents. Shortly thereafter, the federal health agency announced that it had accepted the committee's recommendation, and that vaccines would be available later in the week.
